3.82 USD
▼-0.18-4.63%
盘后 3.63 0.00%
2026-11-20
市值
$237.84M
市盈率
—
EPS
-1.95
股息率
—
52 周区间
2.90 – 7.75
成交量
48.40K
Beta
0.28
目标价
10.22
52W 低 2.9052W 高 7.75
价格走势
公司简介
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015...